IPO Synopsis

Asston Pharmaceuticals Ltd

Registered Office: 4th Flr Office No.A-431 Balaji,Bhavan Plot No.42A Sec-11 CBD, Mumbai - 400614, Maharashtra, India. Phone : +91 22 4973 1411/+91 22 4973 1419   Fax: Email : info@asstonpharmaceuticals.com Website :www.asstonpharmaceuticals.com

Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. 123 per equity share for cash, aggregating up to Rs. 27.56 crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating Rs. 1.39 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating upto Rs. 26.17 crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company. Issue Opens On Closes On 09-Jul-25 11-Jul-25 Money Payable On Application Allotment 123.00 0.00 Minimum Application for shares in Nos : 2000 Further Multiples of : 1000 Cr Lead Managers to the Issue Project Cost (.Cr) 23.95 Sobhagya Capital Options Pvt. Ltd. Project Financed through Current Offer (.Cr) 27.56   Post Issue Equity Share Capital (.Cr) 8.51 Issue Price () 123.00

Projects

Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit Funding the incremental working capital requirements of our company Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company. General corporate purposes

Promoted By

Ashish Narayan Sakalkar

Saili Jayaram More

Sachin Chandrakant Badakh

Listing At

BSE - SME

Registrar to the Issue

No Data Available